Summary

The Global Allergy Diagnostics Market is valued at US$ 5.92 Billion in 2025 and is forecast to reach US$ 10.36 Billion by 2031, growing at a CAGR of 9.8% (2026–2031), driven by rising allergy prevalence, expanding reimbursement, and adoption of multiplex immunoassay platforms.

North America is the largest market with a 38% share in 2025, led by the United States at US$ 1,850 Million across 17 profiled countries. Asia Pacific is the fastest-growing region, expanding at a CAGR above 12% as China and India scale diagnostic infrastructure.

In vitro specific-IgE immunoassays account for 58% of test-type revenue in 2025; reagents and kits represent 52% of product/service spend; serum/plasma-based sample collection leads at 68% of in vitro test volume.

The market spans 15 profiled companies; Thermo Fisher Scientific, Siemens Healthineers and Danaher Corporation together account for roughly 47.8% of 2025 revenue, with the remainder split across specialist and regional players.

Component-resolved diagnostics, AI-assisted result interpretation, and at-home/direct-to-consumer testing are set to reshape the competitive and product landscape through 2031, favoring platform vendors with molecular and digital capabilities.

ページTOPに戻る

Table of Contents

1. Introduction & Report Scope
1.1 Scope & Methodology

2. Global Allergy Diagnostics Market Segmentation
2.1 By Test Type
2.2 By Product & Service
2.3 By Allergen Type
2.4 By End User
2.5 By Sample Type
2.6 By Distribution Channel
2.7 Segmentation Summary
2.8 Market Structure — Latest Reported Mix

3. Global Allergy Diagnostics Market Analysis
3.1 Market Snapshot
3.2 Current Market Trend
3.3 Predicted Market Trend
3.4 Market Value Reconciliation
3.5 Pricing Analysis
3.6 Regulatory Landscape
3.7 Market Attractiveness Analysis

4. Regional Allergy Diagnostics Market Analysis
4.1 Global Regional Comparison
4.2 North America Allergy Diagnostics Market
United States Allergy Diagnostics Market
Canada Allergy Diagnostics Market
4.3 Europe Allergy Diagnostics Market
Germany Allergy Diagnostics Market
United Kingdom Allergy Diagnostics Market
France Allergy Diagnostics Market
Italy Allergy Diagnostics Market
4.4 Asia Pacific Allergy Diagnostics Market
China Allergy Diagnostics Market
Japan Allergy Diagnostics Market
India Allergy Diagnostics Market
South Korea Allergy Diagnostics Market
Australia Allergy Diagnostics Market
4.5 Latin America & MEA Allergy Diagnostics Market
Brazil Allergy Diagnostics Market
Mexico Allergy Diagnostics Market
Saudi Arabia Allergy Diagnostics Market
South Africa Allergy Diagnostics Market

5. Competitive Landscape
5.1 Competitive Landscape Introduction
5.2 Market Share Analysis
5.3 Market Share Trend, 2023–2025
5.4 Recent Developments
5.5 Market Concentration & Entry Barriers

6. Company Profiles
6.1 Thermo Fisher Scientific
6.2 Siemens Healthineers
6.3 Danaher Corporation
6.4 Bio-Rad Laboratories
6.5 Stallergenes Greer
6.6 Hycor Biomedical
6.7 EUROIMMUN AG
6.8 ALK-Abelló
6.9 Quidel Corporation
6.10 Hitachi Chemical Diagnostics
6.11 Omega Diagnostics Group
6.12 R-Biopharm AG
6.13 Lincoln Diagnostics Inc.
6.14 Biomerica Inc.
6.15 Genesis Diagnostics Ltd.

7. Market Dynamics
7.1 Growth Drivers
7.2 Market Challenges
7.3 Market Trends
7.4 Technology Landscape
7.5 Reimbursement Landscape by Region

8. Strategic Outlook
8.1 Strategic Recommendations
8.2 Investment Themes for Investors
8.3 Case Study — Multiplex Adoption in a Reference Lab Network
8.4 Forward Outlook & Conclusion
Table of Figures
Fig. 1 — Allergy Diagnostics Market By Test Type (% of 2025 Revenue, US$)
Fig. 2 — Allergy Diagnostics Market By Product & Service (% of 2025 Revenue, US$)
Fig. 3 — By Allergen Type (% of 2025 Revenue, US$)
Fig. 4 — Allergy Diagnostics Market By End User (% of 2025 Revenue, US$)
Fig. 5 — Allergy Diagnostics Market By Sample Type (% of 2025 Revenue, US$)
Fig. 6 — Allergy Diagnostics Market By Distribution Channel (% of 2025 Revenue, US$)
Fig. 7 — Leading Segment by Axis, 2025 Global Revenue Share (US$)
Fig. 8 — Market Structure, Latest Reported Mix — Three Views (US$)
Fig. 9 — Global Allergy Diagnostics Market Size, 2023–2025 (US$ Billion)
Fig. 10 — Global Allergy Diagnostics Market Forecast, 2026–2031 (US$ Billion)
Fig. 11 — Region-Wise Value Reconciliation, 2025 vs. 2031 (US$ Million)
Fig. 12 — Average Test Pricing by Region and Test Type, 2025 (US$)
Fig. 13 — Regional Regulatory & Reimbursement Landscape, 2025–2026
Fig. 14 — Region-Wise Market Size, 2025 vs. 2031 (US$ Million)
Fig. 15 — North America Market by Country (US$ Million)
Fig. 16 — United States Allergy Diagnostics Market Forecast (US$ Million)
Fig. 17 — Canada Allergy Diagnostics Market Forecast (US$ Million)
Fig. 18 — Europe Allergy Diagnostics Market by Country (US$ Million)
Fig. 19 — Germany Allergy Diagnostics Market Forecast (US$ Million)
Fig. 20 — United Kingdom Allergy Diagnostics Market Forecast (US$ Million)
Fig. 21 — France Allergy Diagnostics Market Forecast (US$ Million)
Fig. 22 — Italy Allergy Diagnostics Market Forecast (US$ Million)
Fig. 23 — Asia Pacific Allergy Diagnostics Market by Country (US$ Million)
Fig. 24 — China Allergy Diagnostics Market Forecast (US$ Million)
Fig. 25 — Japan Allergy Diagnostics Market Forecast (US$ Million)
Fig. 26 — India Allergy Diagnostics Market Forecast (US$ Million)
Fig. 27 — South Korea Allergy Diagnostics Market Forecast (US$ Million)
Fig. 28 — Australia Allergy Diagnostics Market Forecast (US$ Million)
Fig. 29 — Latin America & MEA Market by Country (US$ Million)
Fig. 30 — Brazil Allergy Diagnostics Market Forecast (US$ Million)
Fig. 31 — Mexico Allergy Diagnostics Market Forecast (US$ Million)
Fig. 32 — Saudi Arabia Allergy Diagnostics Market Forecast (US$ Million)
Fig. 33 — South Africa Allergy Diagnostics Market Forecast (US$ Million)
Fig. 34 — Allergy Diagnostics Market Share by Company, 2025 (US$ Million)
Fig. 35 — Top Five Companies' Revenue Trend, 2023–2025 (US$ Million)
Fig. 36 — Regional Reimbursement Landscape and Payer Mix, 2025–2026